Dx Dialogues: Acute Myeloid Leukemia

Naval Daver, MD, hematologist-oncologist and Director of the Leukemia Research Alliance Program at MD Anderson Cancer Center, explores the evolving landscape of relapsed/refractory AML, including AI-driven treatment strategies, next-generation sequencing for MRD assessment, and molecular profiling approaches to identify actionable mutations in R/R AML.